IMMUNOPRECISE ANTIBODIES LTD's ticker is IPA and the CUSIP is 45257F200. A total of 24 filers reported holding IMMUNOPRECISE ANTIBODIES LTD in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 939,475 | $3,570,000 | 0.19% |
| Ikarian Capital, LLC | 61,433 | $237,000 | 0.04% |
| Gradient Capital Advisors, LLC | 20,000 | $76,000 | 0.04% |
| WEST PACES ADVISORS INC. | 1,665 | $6,327 | 0.00% |
| CIBC WORLD MARKET INC. | 47,427 | $183,000 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 15,364 | $59,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 2,600 | $10,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 1,861 | $7,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 17,484 | $67,000 | 0.00% |